John H. Rodman

3.2k total citations
66 papers, 2.4k citations indexed

About

John H. Rodman is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Infectious Diseases. According to data from OpenAlex, John H. Rodman has authored 66 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pediatrics, Perinatology and Child Health, 13 papers in Oncology and 12 papers in Infectious Diseases. Recurrent topics in John H. Rodman's work include Pharmaceutical studies and practices (17 papers), HIV/AIDS drug development and treatment (11 papers) and Childhood Cancer Survivors' Quality of Life (10 papers). John H. Rodman is often cited by papers focused on Pharmaceutical studies and practices (17 papers), HIV/AIDS drug development and treatment (11 papers) and Childhood Cancer Survivors' Quality of Life (10 papers). John H. Rodman collaborates with scholars based in United States, Switzerland and Canada. John H. Rodman's co-authors include William E. Evans, Mary V. Relling, Ching‐Hon Pui, William R. Crom, James M. Boyett, Brian L. Robbins, W R Crom, Joseph J. Buckley, Douglas E. Koehntop and Gaston K. Rivera and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

John H. Rodman

65 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John H. Rodman United States	27	837	537	455	422	324	66	2.4k
Yves Vanrenterghem Belgium	36	1.2k 1.5×	910 1.7×	610 1.3×	561 1.3×	529 1.6×	109	6.3k
Flavio Gaspari Italy	45	795 0.9×	353 0.7×	307 0.7×	704 1.7×	115 0.4×	128	7.1k
Vijay Warty United States	27	821 1.0×	304 0.6×	427 0.9×	437 1.0×	313 1.0×	77	3.0k
Stephen J. Tomlanovich United States	30	463 0.6×	448 0.8×	350 0.8×	263 0.6×	235 0.7×	48	3.4k
Annick Rousseau France	30	694 0.8×	208 0.4×	369 0.8×	252 0.6×	363 1.1×	74	2.5k
Pamala A. Jacobson United States	29	752 0.9×	315 0.6×	371 0.8×	319 0.8×	400 1.2×	131	2.6k
Timothy H. Mathew Australia	32	423 0.5×	638 1.2×	450 1.0×	298 0.7×	125 0.4×	101	4.2k
Jean‐Paul Squifflet Belgium	29	625 0.7×	1.4k 2.6×	491 1.1×	262 0.6×	185 0.6×	102	4.7k
Maria Shipkova Germany	40	1.0k 1.2×	680 1.3×	407 0.9×	1.1k 2.7×	603 1.9×	123	5.0k
Mario Regazzi Italy	36	483 0.6×	252 0.5×	410 0.9×	369 0.9×	869 2.7×	136	3.6k

Countries citing papers authored by John H. Rodman

Since Specialization

Citations

This map shows the geographic impact of John H. Rodman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Rodman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Rodman more than expected).

Fields of papers citing papers by John H. Rodman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John H. Rodman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Rodman. The network helps show where John H. Rodman may publish in the future.

Co-authorship network of co-authors of John H. Rodman

This figure shows the co-authorship network connecting the top 25 collaborators of John H. Rodman. A scholar is included among the top collaborators of John H. Rodman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John H. Rodman. John H. Rodman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chadwick, Ellen G., Edmund V. Capparelli, Ram Yogev, et al.. (2008). Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results. AIDS. 22(2). 249–255. 59 indexed citations

Chadwick, Ellen G., John H. Rodman, Paula Britto, et al.. (2005). Ritonavir-Based Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Infants Younger Than 24 Months of Age. The Pediatric Infectious Disease Journal. 24(9). 793–800. 31 indexed citations

Rodman, John H.. (2001). Design of antiretroviral clinical trials for HIV-1 infected pregnant women and their newborn infants. Seminars in Perinatology. 25(3). 170–176. 2 indexed citations

Dagher, Ramzi, Susan G. Kreissman, Kent A. Robertson, et al.. (1998). High Dose Chemotherapy With Autologous Peripheral Blood Progenitor Cell Transplantation in an Anephric Child With Multiply Recurrent Wilms Tumor. Journal of Pediatric Hematology/Oncology. 20(4). 357–360. 12 indexed citations

Rodman, John H.. (1997). ACCP Strategic Planning Conference: Issues and Trends in Clinical Pharmacy Research. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(5). 1068–1072. 1 indexed citations

Boucher, Bradley A., et al.. (1997). Effect of Acute Phase Response on Phenytoin Metabolism in Neurotrauma Patients. The Journal of Clinical Pharmacology. 37(2). 129–139. 26 indexed citations

Tonda, Margaret, et al.. (1996). Carboplatin pharmacokinetics in young children with brain tumors. Cancer Chemotherapy and Pharmacology. 38(5). 395–400. 11 indexed citations

Murry, Daryl J., Timothy W. Synold, Ching‐Hon Pui, & John H. Rodman. (1995). Renal Function and Methotrexate Clearance in Children With Newly Diagnosed Leukemia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 15(2). 144–149. 18 indexed citations

Wilson, R. J., et al.. (1994). Superiority of aztreonam/clindamycin compared with gentamicin/clindamycin in patients with penetrating abdominal trauma. The American Journal of Surgery. 167(3). 291–296. 22 indexed citations

10.

Relling, Mary V., Diane Fairclough, D. Ayers, et al.. (1994). Patient characteristics associated with high-risk methotrexate concentrations and toxicity.. Journal of Clinical Oncology. 12(8). 1667–1672. 168 indexed citations

11.

Baker, Donald K., Mary V. Relling, Ching‐Hon Pui, et al.. (1992). Increased teniposide clearance with concomitant anticonvulsant therapy.. Journal of Clinical Oncology. 10(2). 311–315. 50 indexed citations

12.

Evans, William E., John H. Rodman, M V Relling, et al.. (1992). Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia.. Journal of Pharmacology and Experimental Therapeutics. 260(1). 71–77. 14 indexed citations

13.

Peck, Carl C., William H. Barr, Leslie Z. Benet, et al.. (1992). Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development. Journal of Pharmaceutical Sciences. 81(6). 605–610. 49 indexed citations

14.

Petros, William P., John H. Rodman, Michael Christensen, et al.. (1992). Variability in Teniposide Plasma Protein Binding Is Correlated With Serum Albumin Concentrations. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 12(4). 273–277. 12 indexed citations

15.

Kellie, Stewart J., William M. Crist, Ching‐Hon Pui, et al.. (1991). Hypersensitivity reactions to epipodophyllotoxins in children with acute lymphoblastic leukemia. Cancer. 67(4). 1070–1075. 28 indexed citations

16.

Evans, William E., Mary V. Relling, John H. Rodman, et al.. (1989). Hepatic Drug Clearance in Children: Studies with Indocyanine Green as a Model Substrate. Journal of Pharmaceutical Sciences. 78(6). 452–456. 37 indexed citations

17.

Evans, William E., et al.. (1989). Anticancer Therapy as a Pediatric PharmacodynamicParadigm. Developmental Pharmacology and Therapeutics. 13(2-4). 85–95. 5 indexed citations

18.

Bottorff, Michael B., et al.. (1988). Pharmacokinetics and Pharmacodynamics of Urapidil in Severe Hypertension. The Journal of Clinical Pharmacology. 28(5). 420–426. 7 indexed citations

19.

Boucher, Bradley A., et al.. (1987). Disposition of phenytoin in critically ill trauma patients.. PubMed. 6(11). 881–7. 16 indexed citations

20.

Elenbaas, Robert M., William E. Evans, Philip P. Gerbino, et al.. (1985). Definition of Clinical Pharmacy as a Specialty in Clinical Practice. Drug Intelligence & Clinical Pharmacy. 19(2). 149–150.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact